SISU Inc

SISU Inc. develops pharmaceuticals focused on cellular stress response for neurodegenerative diseases and oncology. The Company advances HSF1 activators and selective degraders through drug discovery and development. SISU Inc serves healthcare providers and researchers in the United States.